Advertising Prescription Drugs to the Public: Headache or Relief?
探讨处方药直接面向消费者广告的争议，分析制药商、医生、监管者和消费者四方的观点、法律问题及成本效益，并为制造商和监管者提出建议。
This paper explores the issue of direct-to-consumer (DTC) advertising of prescription drugs. The viewpoints of the four major groups involved—pharmaceutical manufacturers, physicians, regulators and consumers—are discussed, the legal questions such advertising raises are examined and the costs and benefits of it are reviewed. Finally, some recommendations are developed to assist the two groups most actively involved: manufacturers and regulators.